Support Our Work

Please donate so we can continue our work to reduce the stigma of psychiatric illness, encourage research, and support educational activities for behavioral health professionals and the public. Ways you can donate and help are on our Support and Donations page. Thank you!

More Info

Latest News Around the Web

Stress, depression common for women at time of MI and two months later

According to HealthDay (10/16), “For women with myocardial infarction (MI), stress and depression are common at the time of MI and two months later,” a study published in the Journal of the American College of Cardiology shows. Investigators “found that women with MINOCA (myocardial infarction with nonobstructive coronary arteries) were younger and more diverse than women with MI-CAD (myocardial infarction-coronary artery disease).”

Related Links:

— “Stress, Depression Common Among Women With Myocardial Infarction,”Elana Gotkine, HealthDay , October 16, 2023

Patients Needing Medications For OUD Should Continue To Receive Them Prior To Surgery, Researchers Conclude

Medscape (10/16, Banks, Subscription Publication) reports, “Patients who need medications for opioid use disorder (OUD) should continue to receive them prior to surgery, rather than stopping those drugs, as has been the convention,” according to findings from “a new analysis of more than five million surgeries presented at Anesthesiology 2023.”

Related Links:

Medscape (requires login and subscription)

With People Not Taking Antidepressants, People Taking Antidepressants Appear To Lose Similar Amount Of Weight On Semaglutide 2.4 Mg, Analysis Of Four Trials Indicates

MedPage Today (10/16, Haelle) reports, “People taking antidepressants lost a similar amount of weight on semaglutide 2.4 mg (Wegovy) compared with those not taking antidepressants, according to a post-hoc analysis of four STEP trials” presented at the ObesityWeek annual meeting. The study revealed that “participants on antidepressants taking the GLP-1 receptor agonist lost an average 10.7% to 19% of their baseline body weight compared to a 9.5% to 15.9% loss in participants not taking antidepressants.”

Related Links:

MedPage Today (requires login and subscription)

Use Of Mirtazapine, Nortriptyline, And Trazodone Among Hospitalized Patients Appears Tied To Greater Risk Of CDI, Study Suggests

HCPlive (10/16, Brooks) reports, “Hospitalized patients using mirtazapine, nortriptyline, and trazodone are at a greater risk of Clostridioides difficile infection (CDI),” researchers concluded in a study that compared “48,720 patients developed CDI…to 55,615,700 who did not.” The findings were published in the July-Sept. Issue of the journal Arquivos de Gastroenterologia.

Related Links:

— “Antidepressant Use Linked to Increased Risk of Hospital-Onset C Diff,”Abigail Brooks, HCPlive, October 16, 2023

Substantial Proportion Of Young Children From Low-Income Families Appear To Have Elevated Levels Of Emotional, Behavioral Health Problems Seen In Pediatric Primary Care, Researchers Conclude

MedPage Today (10/16, Henderson) reports, “A substantial proportion of young kids from low-income families had elevated levels of emotional and behavioral health problems seen in pediatric primary care, researchers” concluded in findings published online in JAMA Pediatrics. In the “retrospective cohort study of 15,218 children ages two to six years, fully one-third of children had screening tool scores reflecting clinically elevated levels of emotional and behavioral problems over time.” Additionally, “relative to those whose scores remained low over time, kids in the elevated score groups were more likely to be male, white, have public insurance, have had a social need, and a caregiver with depression,” the study revealed.

Related Links:

MedPage Today (requires login and subscription)

Foundation News

Nothing Found

It seems we can’t find what you’re looking for. Perhaps searching can help.